Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis

In conclusion, BMB proved to be generally safe and beneficial in this geriatric cancer patient cohort beyond the age of 85 years. However, the a dvantages of lymphoma staging in this patient population warrant further consideration.
Source: Annals of Hematology - Category: Hematology Source Type: research